SAT0446 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and previous inadequate response to tumour necrosis factor-inhibitors Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2017
has subject area
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- 1117 Public Health and Health Services (FoR)
- Arthritis & Rheumatology (Science Metrix)
published in
- Annals of the Rheumatic Diseases Journal